Future studies should focus on elucidating the precise pathways through which GDF15 modulates EE and determining whether or not its long-term application can be harnessed for therapeutic purposes in obesity. This evidence concerns the gene GDF15 and obesity due to melanocortin 4 receptor deficiency.